ELSAWY, M. Chimeric antigen receptor T-cell therapy for relapsed and refractory large B-cell lymphoma: A Canadian perspective. Canadian Hematology Today, Toronto, Canada, v. 1, n. 2, p. 26–33, 2022. DOI: 10.58931/cht.2022.1214. Disponível em: https://canadianhematologytoday.com/article/view/1-2-4-elsawy. Acesso em: 3 may. 2024.